Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 701-725 of 1,000 matching filings.

Per page
25
Current page
29
4

FORM 4 -

Filing date
08 May 2014
Reporting date
06 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 May 2014
Reporting date
06 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 May 2014
Reporting date
06 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 May 2014
Reporting date
06 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
08 May 2014
Reporting date
08 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-50549

DEFA14A

Filing date
15 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
15 Apr 2014
Reporting date
14 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
07 Apr 2014
Reporting date
03 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
04 Apr 2014
Reporting date
03 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
04 Apr 2014
Reporting date
04 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-50549

AUTO-GENERATED PAPER DOCUMENT

Filing date
03 Apr 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Apr 2014
Reporting date
01 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Apr 2014
Reporting date
01 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Apr 2014
Reporting date
01 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-50549

DEF 14A

Filing date
24 Mar 2014
Reporting date
06 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Mar 2014
Reporting date
19 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
17 Mar 2014
Reporting date
06 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79588

GTX, INC. SCHEDULE 13G MARCH 6, 2014

Filing date
17 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

GTX, INC. SCHEDULE 13D AMENDMENT 6 MARCH 6, 2014

Filing date
13 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-50549

PRE 14A

Filing date
13 Mar 2014
Reporting date
06 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Mar 2014
Reporting date
06 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

GTX, INC. SCHEDULE 13D AMENDMENT 5 MARCH 6, 2014

Filing date
10 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-213088

D/A filing

Filing date
07 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-213088

D filing

Filing date
06 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .